Perspective Therapeutics, Inc. Stock
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | +4.58% | -8.57% | +298.01% |
Financials (USD)
Sales 2024 * | 523K | Sales 2025 * | 321K | Capitalization | 939M |
---|---|---|---|---|---|
Net income 2024 * | -54M | Net income 2025 * | -64M | EV / Sales 2024 * | 1,796 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2,922 x |
P/E ratio 2024 * |
-17
x | P/E ratio 2025 * |
-14.8
x | Employees | 118 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.58% |
Latest transcript on Perspective Therapeutics, Inc.
1 day | +4.58% | ||
1 week | -8.57% | ||
Current month | -4.76% | ||
1 month | +8.84% | ||
3 months | +82.29% | ||
6 months | +514.91% | ||
Current year | +298.01% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 52 | 23-02-02 |
Mark Austin
DFI | Director of Finance/CFO | 37 | 17-06-30 |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 23-02-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 23-05-31 |
Lori Woods
CHM | Chairman | 61 | 23-02-02 |
Director/Board Member | 58 | 23-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.6 | +4.58% | 5,526,230 |
24-05-16 | 1.53 | -2.55% | 10,705,556 |
24-05-15 | 1.57 | -10.80% | 18,110,425 |
24-05-14 | 1.76 | +1.15% | 6,696,168 |
24-05-13 | 1.74 | -0.57% | 5,643,951 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+298.01% | 939M | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- CATX Stock